A Phase I-II Study of Interferon-gamma Plus Weekly Paclitaxel, Trastuzumab and Pertuzumab in Patients With HER-2 Positive Breast Cancer
Phase of Trial: Phase I/II
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Interferon gamma-1b (Primary) ; Paclitaxel; Pertuzumab; Trastuzumab
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Oct 2017 Planned End Date changed from 1 Jun 2021 to 1 Jun 2022.
- 28 Apr 2017 Status changed from not yet recruiting to recruiting.
- 19 Apr 2017 New trial record